Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
Data on bioengineering published by researchers at Australian National University
April 1st, 2008
According to a study from Canberra, Australia, "Objectives and methods The aim of this study was to investigate genetic variation in glutathione transferase omega 1 (GST01-1) in Atacamenos, an indigenous population from Chile that has been exposed to environmental arsenic for many generations. GST01-1 is thought to catalyse the rate-limiting step in the biotransformation of arsenic in humans and may modulate the response of cancer patients to arsenic trioxide therapy." "Allele frequencies were determined by PCR-based methods and a polymorphic variant (GST01-1 VaI236) was expressed in Escherichia coli and functionally characterized. Urinary arsenic profiles were...
Source: Cancer Weekly (2008-04-01)
|
